These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38223518)

  • 1. FGF23-related hypophosphatemic rickets preceding the onset of systemic lupus erythematosus: A juvenile case.
    Tabei Y; Ohtsu Y; Shimada M; Wada A; Hamajima E; Osawa Y; Takizawa T
    Clin Case Rep; 2024 Jan; 12(1):e8420. PubMed ID: 38223518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.
    Hidaka N; Kato H; Koga M; Katsura M; Oyama Y; Kinoshita Y; Fukumoto S; Makita N; Nangaku M; Ito N
    Bone Rep; 2021 Dec; 15():101144. PubMed ID: 34901334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
    Kinoshita Y
    Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding of phosphate homeostasis and related disorders.
    Michigami T
    Endocr J; 2022 Aug; 69(8):881-896. PubMed ID: 35831119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK; Carpenter TO
    Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in the mobility of a patient with fibroblast growth factor 23-related hypophosphatemic osteomalacia and decompensated liver cirrhosis in response to burosumab: a case report.
    Toi N; Imanishi Y; Nagata Y; Kurajoh M; Morioka T; Shoji T; Shinto Y; Emoto M
    Endocr J; 2023 Apr; 70(4):419-426. PubMed ID: 36575021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.
    Fukumoto S
    J Mol Endocrinol; 2021 Feb; 66(2):R57-R65. PubMed ID: 33295878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to Hypophosphatemic Rickets.
    Ackah SA; Imel EA
    J Clin Endocrinol Metab; 2022 Dec; 108(1):209-220. PubMed ID: 35981346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23.
    Ito N; Kubota T; Kitanaka S; Fujiwara I; Adachi M; Takeuchi Y; Yamagami H; Kimura T; Shinoda T; Minagawa M; Okazaki R; Ozono K; Seino Y; Fukumoto S
    J Bone Miner Metab; 2021 Nov; 39(6):1066-1075. PubMed ID: 34255195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rickets/Osteomalacia. FGF23-related hypophosphatemic rickets/osteomalacia.].
    Fukumoto S
    Clin Calcium; 2018; 28(10):1313-1317. PubMed ID: 30269112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphatemia in juvenile patients with systemic lupus erythematosus.
    Fujiwara I; Ogawa E; Kondo Y; Ohura T; Iinuma K
    Pediatr Int; 2003 Feb; 45(1):23-30. PubMed ID: 12654064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Therapies for Hypophosphatemia-Related to FGF23 Excess.
    Athonvarangkul D; Insogna KL
    Calcif Tissue Int; 2021 Jan; 108(1):143-157. PubMed ID: 32504139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report.
    Sato T; Muroya K; Asakura Y; Yachie A; Nishimura G; Aida N; Machida J; Tanaka Y; Hasegawa T; Adachi M
    Am J Med Genet A; 2015 Oct; 167A(10):2430-4. PubMed ID: 26059403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatonins: From Discovery to Therapeutics.
    Kritmetapak K; Kumar R
    Endocr Pract; 2023 Jan; 29(1):69-79. PubMed ID: 36210014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.
    Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X
    J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 and Hypophosphatemic Rickets/Osteomalacia.
    Takashi Y; Kawanami D; Fukumoto S
    Curr Osteoporos Rep; 2021 Dec; 19(6):669-675. PubMed ID: 34755323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
    Michigami T
    Clin Calcium; 2013 Oct; 23(10):1429-35. PubMed ID: 24076640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.